Keep up to date on the latest medical news at MDLinx - FREE!

  • Stay current on the latest medical literature, research and clinical news
  • MD jobs and physician job search at our new medical job Career Center
  • Receive invitations to paid market research
  • Search Clinical Trials and Medical Conferences

register to view free medical at articles at MDLinx

Follow Us

Posts by category

MDLinx Blog - Medical News and more.

Current Articles | RSS Feed RSS Feed

World’s Largest Physician Panel Formed As M3 USA Purchases EU-Based EMS Research

M3 GR logo web tag

M3 Global Research combines MDLinx and EMS to offer online access to 1.3 million healthcare professionals

Washington, DC, November 22, 2010 – M3 USA, parent company of MDLinx, a leading medical market research firm, has signed an agreement to purchase EU-based EMS Research, a company specializing in quantitative and qualitative market research for clients in healthcare and other vertical markets.

The acquisition creates the largest verified provider of physicians and other healthcare professionals in the world.  This new international division will be designated M3 Global Research.  With offices in the US, UK, Germany, Japan, Korea and China, M3 Global Research will offer access to 1.3 million verified doctors and other healthcare professionals, differentiated into more than 700 subspecialties.

M3 Global Research will provide the highest standard of direct access, utilizing its proprietary physician panels, online survey tools, call centers, fieldwork studios, and in-house project managers in offices around the world.

“EMS Research has always prided itself on our superior market research capabilities.  By teaming with M3, we have greatly expanded the depth and breadth of our abilities on a global perspective,” said Neil Jarvis, Director at EMS.

“Europe was the missing component in our market research global coverage strategy.  The EMS acquisition firmly secures our place as the healthcare market research industry leader, and equips us with the largest verified panel of healthcare professionals in the world,” said Aki Tomaru, CEO of M3 USA.  “Our clients will now enjoy unparalleled global reach as they gather insights from healthcare professionals and experience our best-in-industry, single source service.”

M3 Global Research and M3 USA

M3 Global Research is the market research division of Tokyo-based M3 Inc. (JP:2413) operating globally with a proprietary healthcare professional panel of 1.3 million  respondents in more than 60 countries.  The division was created by uniting the worldwide panels of MDLinx in the USA, EMS Research in Europe, and M3 companies across Asia.  M3 Global Research offers a broad range of capabilities including quantitative, qualitative, and omnibus surveys utilizing call centers and in-country project managers.  M3 has provided solutions for every top 20 pharmaceutical company in the world.  For more information, visit or email requests to

EMS Research

EMS Research, headquartered in London, England, was founded in 1999 and is Europe’s leading in-house medical fieldwork company.  M3 Global Research will maintain EMS’s unparalleled research quality at competitive cost via effective management and expansion of research assets across Europe,  including respondent databases, pan-European project teams, in-house moderators, online survey tools, call centers, field teams and viewing facilities.

Greg Jones for M3 Global Research

Trending Medical Articles

Friday, Jul 11, 2014
Journal of Clinical Microbiology, 07/11/2014 Petty TJ, et al. – The study evaluate that high–throughput sequencing (HTS) provides the means to analyze clinical specimens at unprecedented molecular detail. However, results obtained in this pilot study indicate that the overall detection success rate, coupled to the ease of interpreting the analysis reports, makes it worth...Read More
Friday, Jul 18, 2014
PLOS ONE, 07/18/2014 Veit LE, et al. – The study aims to determine the vitamin D status of patients with inflammatory bowel disease (IBD) by comparing their serum 25(OH)D concentration to that of healthy controls. There is no difference in mean serum 25(OH)D concentration between children and adolescents with IBD and controls. However, IBD subjects with elevated ESR have significantly...Read More
Wednesday, Jun 11, 2014
Journal of Acupuncture and Tuina Science, 06/11/2014 Huang F, et al. – The purpose of this study is to observe the clinical efficacy of electroacupuncture plus interferential current therapy (ICT) in treating chronic fatigue syndrome (CFS), and to explore the mechanism. The result reveal that electroacupuncture plus ICT can produce a remarkable efficacy in treating CFS. Xiong Chen...Read More
Thursday, Jul 10, 2014
Journal of Leukocyte Biology, 07/10/2014 Shirey KA, et al. – The findings suggest that therapeutic manipulation of macrophage differentiation to enhance the alternatively activated macrophages (AAMs) phenotype is a viable approach for ameliorating RSV–induced disease. Stefanie N. Vogel and Kari Ann Shirey (07/21/2014) comments: RSV remains a leading cause of respiratory...Read More
Monday, Jul 21, 2014
Frontiers in Oncology, 07/21/2014 Saigal K, et al. – In this research, low–dose weekly carboplatin is added to Cx + RT for patients unsuitable for HD–DDP, to find out its efficacy. The researchers hypothesize that the addition of a well–tolerated cytotoxic chemotherapy agent may improve the therapeutic ratio of Cx + RT in patients who are poor candidates for more...Read More